Dr. Reddy's Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 24, 2025. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.
DRREDDY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Reddy's Laboratories held its 41st AGM on July 24, 2025, via video conferencing from 11:00 AM to 12:38 PM IST. 85 members holding 22,33,11,552 shares attended the meeting. All six resolutions were passed with overwhelming shareholder approval, including adoption of FY25 audited financial statements (99.83% in favor), declaration of a dividend of Rs. 8 per equity share for FY2025 (99.99% in favor), and re-appointment of Mr. G V Prasad as Co-Chairman and Managing Director (98.56% in favor). Resolutions also covered appointment of M/s. Makarand M. Joshi & Co. as secretarial auditor (99.99% in favor) and ratification of cost auditor remuneration. The Scrutinizer's report from Mehta & Mehta confirmed all resolutions passed by requisite majority.
Routine regulatory filing confirming shareholder approval of routine AGM matters. The Rs. 8 per share dividend is confirmed, and the re-appointment of G V Prasad as Co-Chairman and MD ensures leadership continuity. No material surprise or negative signal — all resolutions received near-unanimous support, with the lowest being 98.56% for G V Prasad's executive re-appointment.